期刊文献+

靶向PI3Kp85α的siRNA抑制人卵巢癌细胞系生长的实验研究

Inhibitory Effects of Small Interfering RNA Targeting on the Growth of Human Ovarian Carcinoma Cells Phosphoinositide 3-kinase Regulatory Subunit p85 alpha
下载PDF
导出
摘要 目的:探讨siRNA靶向抑制卵巢癌细胞磷脂酰肌醇3-激酶调节亚基p85α(phosphoinositide 3-kinase regulatory subunitp85 alpha,P13Kp85α)表达后,对肿瘤细胞增殖和侵袭的影响。方法:应用siRNA靶向PI3Kp85α转染人卵巢癌细胞系SKOV3,Re-altime PCR检测目的基因mRNA表达,Western blot和免疫荧光技术检测PI3Kp85α、AKT1、AKT2和Ki67的表达变化;M_rr法和an-nexin V标记评价细胞的增殖活性和凋亡,流式细胞法分析细胞周期.Transwell法分析侵袭能力。结果:转染PI3Kp85αsiRNA后PI3Kp85αmRNA表达下降;PI3Kp85α、AKT1、AKT2和Ki67的蛋白表达水平均明显降低(P<0.01)。卵巢癌细胞增殖活性明显受到抑制,细胞周期在G_0/G_1期有明显的阻滞,早期凋亡的细胞教明显增多,细胞的运动迁移能力降低(P<0.01),侵袭能力减弱(P<0.01)。结论:靶向PI3Kp85α的siRNA技术可抑制卵巢癌细胞PI3Kp85α的表达,进而抑制肿瘤细胞的生长,这可能成为卵巢癌基因治疗的新靶点。 Objective: This study investigates the growth inhibition effect of small interfering RNA ( siRNA ) targeting Phos- phoinositide 3-kinase Regulatory Subunit p85 alpha (PI3Kp85α) on ovarian carcinoma cells. Methods: RNA interference ( RNAi ) tech- nology was used to observe the inhibitory effect of siRNA on the growth of human ovarian carcinoma SKOV3 cells. The expression of PI3Kp85α mRNA was detected through real-time polymerase chain reaction after the transfection. The expression of PI3Kp85α, AKT1, AKT2, and Ki-67 was also studied using Western blot and immunofluorescence staining after transfection. Moreover, MTT methods and annexin V staining were used to evaluate cell proliferation and apoptosis. Flow cytometry was used for cell cycle analysis, and tu- mor invasion was examined through Transwell analysis. Results: SKOV3 PI3Kp85α mRNA expression was significantly knocked down after transfection with siRNA. The SKOV3 cells transfected with siRNA targeting PI3Kp85α showed lower proliferation activity, whereas the expression of PI3Kp85α, AKT1, AKT2, and Ki-67 was downregulated compared with the control and nonsense siRNA transfected cells. The transfected cells had higher apoptosis rate and most cells arrested in the G0/G1 phase. Moreover, the migration and invasive ability of the ovarian carcinoma cells was attenuated. Conclusion: Silencing PI3Kp85α genes with siRNA downregulated the mRNA expression of PI3Kp85α in ovarian carcinoma endothelial cells, blocked cell proliferation and migration, arrested cell cycle, and induced apoptosis in vitro. Therefore, P13Kp85α can be a candidate gene for ovarian cancer gene therapy.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第7期369-372,共4页 Chinese Journal of Clinical Oncology
关键词 PI3Kp85α RNAI 卵巢癌 增殖 PI3Kp85α RNAi Ovarian cancer Proliferation
  • 引文网络
  • 相关文献

参考文献10

  • 1Zhang HY,Zhang PN,Sun H. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplat-in-based chemotherapy[J].European Journal of Obstetrics and Gynecology and Reproductive Biology,2009,(01):81-86.doi:10.1016/j.ejogrb.2009.04.035.
  • 2Dillin A. The specific of small interfering RNA specificity[J].Proc Nat Acd Sci,2003.6289-6291.
  • 3Park CM,Park MJ,Kwak HJ. Ionizing radiation enhances matrix metallop roteinase-2 Secretion and invasion of Glioma cells through src/epidermal growth factor receptor mediated p38/Akt and phos?phatidylinositol 3-kinase/Akt signaling pathways[J].Cancer Research,2006,(17):8511-8519.doi:10.1158/0008-5472.CAN-05-4340.
  • 4Kolasa IK,Rembiszewska A,Felisiak A. PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients[J].Cancer Biology and Therapy,2009,(01):21-26.doi:10.4161/cbt.8.1.7209.
  • 5朱颖军,薛凤霞,高企贤.卵巢癌组织芯片中PI3K p85α,AKT1及Ki-67表达的研究[J].天津医药,2008,36(8):578-580. 被引量:4
  • 6Huang J,Zhang L,Greshock J. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome[J].Genes,Chromosomes and Cancer,2011,(08):606-618.doi:10.1002/gcc.20883.
  • 7Astanehe A,Arenillas D,Wasserman WW. Mechanisms un-derlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer[J].Journal of Cell Science,2008,(Pt5):664-674.
  • 8Karam AK,Santiskulvong C,Fekete M. Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carci-noma cells and regulate matrix-metalloproteinase expression[J].Cy-toskeleton (Hoboken),2010,(08):535-544.
  • 9Li C,Liu VW,Chan DW. LY294002 and metformin coopera-tively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells[J].International Journal of Gynecological Cancer,2012,(01):15-22.doi:10.1097/IGC.0b013e3182322834.
  • 10Tanaka H,Yoshida M,Tanimura H. The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations[J].Clinical Cancer Research,2011,(10):3272-3281.doi:10.1158/1078-0432.CCR-10-2882.

二级参考文献8

  • 1李咏梅,刘晓红,曹晓哲,王力,朱明华.着丝粒蛋白A在原发性肝癌中的表达[J].中华病理学杂志,2007,36(3):175-178. 被引量:12
  • 2Geering B, Cutillas PR, Nock G,et aL Class IA phosphoinositide 3-kinases are obligate p85--p 110 heterodimers[J]. Proc Natl Acad Sci USA, 2007, 104(19):7809-7814.
  • 3Gershtein ES, Scherbakov AM, Shatskaya VA, et al. Phosphatidylinositol 3 -kinase/AKT signalling pathway components in human breast cancer, clinicopathological correlations [J]. Anticancer Res, 2007, 27 (4A):1777-1782.
  • 4Solit DB, Basso AD, Olshen AB, et al. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol[J]. Cancer Res, 2003,63(9):2139-2144.
  • 5Shekar SC, Wu H, Fu Z, et al. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit[J]. J Biol Chem, 2005,280(30):27850-27855.
  • 6Shukla S, Maclennan GT, Hartman DJ,et al. Activation of PI3K-Akt signaling pathway promotes prostate cancer cellinvasion[J]. Int J Cancer,2007, 121(7):1424-1432.
  • 7Murakami D, Tsujitani S, Osaki T,et al. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy[J]. Gastric Cancer,2007,10(1):45-51.
  • 8Kumar A, Carrera AC. New functions for PI3K in the control of cell division [J]. Cell Cyclc,2007,6(14):1696-1698.

共引文献3

;
使用帮助 返回顶部